82 related articles for article (PubMed ID: 6465848)
1. Short-term prognosis of bladder cancer. Evaluation with urinary CEA.
Holmberg V; Nilsson B
Anticancer Res; 1984; 4(3):121-2. PubMed ID: 6465848
[TBL] [Abstract][Full Text] [Related]
2. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
3. Prediction of survival and recurrence in bladder carcinoma.
Nilsson B; Wahren B; Esposti PL; Edsmyr F
Urol Res; 1982; 10(3):109-13. PubMed ID: 7135696
[TBL] [Abstract][Full Text] [Related]
4. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
6. Possibilities for an extended classification of bladder cancer.
Wahren B; Nilsson B; Esposti PL; Edsmyr F; Holmberg V
Urol Res; 1984; 12(4):195-7. PubMed ID: 6495445
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
10. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
[TBL] [Abstract][Full Text] [Related]
11. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
12. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in survival of colorectal cancer patients after surgery.
Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
16. Screening tests for the detection of bladder cancer.
Betkerur V; Hliang V; Baumgartner G; Rao R; Ablin RJ; Guinan PD
Allergol Immunopathol (Madr); 1980; 8(3):169-76. PubMed ID: 7405763
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
Dyrskjøt L; Zieger K; Real FX; Malats N; Carrato A; Hurst C; Kotwal S; Knowles M; Malmström PU; de la Torre M; Wester K; Allory Y; Vordos D; Caillault A; Radvanyi F; Hein AM; Jensen JL; Jensen KM; Marcussen N; Orntoft TF
Clin Cancer Res; 2007 Jun; 13(12):3545-51. PubMed ID: 17575217
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
Lee SE; Park MS
Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
[TBL] [Abstract][Full Text] [Related]
19. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
20. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
